ArticleScience translational medicine2013

PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses.

Victor D Fedorov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.